Speciation of arsenic in urine following intravenous administration of arsthinol in mice
Recent investigations have shown that arsthinol, a trivalent organoarsenic compound (dithiarsolane), has been active in vitro on leukemia cell lines and offers a better therapeutic index than arsenic trioxide, as estimated by the ratio LD 50 /IC 50 . To complete our understanding of its urinary excr...
Saved in:
Published in: | European journal of drug metabolism and pharmacokinetics Vol. 35; no. 1-2; pp. 59 - 65 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Paris
Springer-Verlag
01-09-2010
Médecine & hygiène Springer |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Recent investigations have shown that arsthinol, a trivalent organoarsenic compound (dithiarsolane), has been active in vitro on leukemia cell lines and offers a better therapeutic index than arsenic trioxide, as estimated by the ratio LD
50
/IC
50
. To complete our understanding of its urinary excretion, a sensitive method using liquid chromatography coupled with mass spectrometry (LC-MS) was used. Mice were injected intravenously with a single dose of arsthinol at 0.2 mmol/kg of body weight. The amount of total arsenic in tissues and body fluids was determined by a colorimetric method and urine metabolites were analyzed on a C18 Acclaim PepMap 100 Å column by LC-MS. Our results showed that only three arsenic species (acetarsol, acetarsol oxide and arsthinol) were detected in the first 24-h urine. Overall, this study confirms that the hydrolysis of dithiarsolanes to arsenoxides (i.e. acetarsol oxide) can be followed by an oxidation in arsonic acids (i.e. acetarsol). All these compounds are excreted in the urine. |
---|---|
ISSN: | 0378-7966 2107-0180 |
DOI: | 10.1007/s13318-010-0009-6 |